501 results on '"Illum L"'
Search Results
2. Key Issues in the Use of Cell and Tissue Culture Systems
3. Long circulating microparticulate drug carriers
4. Particulate Systems for Site Specific Drug Delivery
5. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: In vivo studies
6. CriticalSorb™ Promotes Permeation of Flux Markers Across Isolated Rat Intestinal Mucosae and Caco-2 Monolayers
7. Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device
8. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: In vitro characterisation studies
9. The Effect of Blood Sampling Site and Physicochemical Characteristics of Drugs on Bioavailability After Nasal Administration in the Sheep Model
10. Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
11. Development of Systems for Targeting the Regional Lymph Nodes for Diagnostic Imaging: In Vivo Behaviour of Colloidal PEG-Coated Magnetite Nanospheres in the Rat Following Interstitial Administration
12. Application of Novel Biomaterials in Colloidal Drug Delivery Systems
13. Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology
14. Dry Powder CriticalSorb™ Formulations Promote the Absorption of Macromolecules Across the Nasal Mucosa of Rabbits
15. Activation of the Mononuclear Phagocyte System by Poloxamine 908: Its Implications for Targeted Drug Delivery
16. Nanospheres prepared from poly(β-malic acid) benzyl ester copolymers: evidence for their in vitro degradation
17. Nasal administration of an angiotensin antagonist in the rat model: Effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems
18. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms
19. The effect of the nasal cycle on mucociliary clearance
20. Characterisation of poly(lactic acid):poly(ethyleneoxide) (PLA:PEG) nanoparticles using the self-consistent theory modelling approach
21. Nasal delivery of chitosan–DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice
22. Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation
23. Measurement of nasal mucociliary transport rate using the isolated inferior turbinate
24. Self-consistent field modelling of poly(lactic acid)–poly(ethylene glycol) particles
25. Preparation of ultrafine silica- and PEG-coated magnetite particles
26. Chitosan as a novel nasal delivery system for vaccines
27. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation
28. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers
29. Colloidal stability and drug incorporation aspects of micellar-like PLA–PEG nanoparticles
30. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS
31. Key Issues in the Delivery of Peptides and Proteins
32. Particle Charge and Surface Hydrophobicity of Colloidal Drug Carriers
33. Targeting of Colloidal Carriers and the Role of Surface Properties
34. The effect of the nasal cycle on mucociliary clearance
35. Microspheres as Controlled-Release Systems for Parenteral and Nasal Administration
36. OR03-6 Intranasal administration of Human Growth Hormone (CP024) and induction of IGF-1 in healthy volunteers
37. Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow
38. Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences
39. Core−Shell Structure of PLA−PEG Nanoparticles Used for Drug Delivery
40. Intranasal Delivery of Morphine
41. Poly(lactic acid)−Poly(ethylene oxide) (PLA−PEG) Nanoparticles: NMR Studies of the Central Solidlike PLA Core and the Liquid PEG Corona
42. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides
43. Physicochemical Evaluation of Nanoparticles Assembled from Poly(lactic acid)−Poly(ethylene glycol) (PLA−PEG) Block Copolymers as Drug Delivery Vehicles
44. Clearance characteristics of chitosan based formulations in the sheep nasal cavity
45. Transport of Nanoparticles Across the Rat Nasal Mucosa
46. Polylactide-poly(ethylene Glycol) Micellar-like Particles as Potential Drug Carriers: Production, Colloidal Properties and Biological Performance
47. Gastrointestinal transit of dosage forms in the pig
48. Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens
49. 16. A dual radionuclide study to assess the effect of the nasal cycle on nasal drug delivery
50. Schizophrenia and Drug Delivery Systems
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.